This table summarizes and compares the wound healing models, key mechanisms, and therapeutic outcomes of GHK peptides and larger bioactive peptides, highlighting their shared and distinct roles to inform future research and clinical applications
Source and Quality This is where costs vary most dramatically
Both GHK-CU and Epithalon have demonstrated excellent safety profiles in research studies with minimal reported side effects
researchers note it is more selective than older growth-hormone-releasing peptides (GHRPs) like GHRP-6 because it does not meaningfully raise cortisol or prolactin alongside GH
For skin, hair, and healing, the answer looks promising enough that GHK-Cu has stayed relevant for decades instead of disappearing like most peptide trends do
When someone reports an unexpected reaction, it is often impossible to tell whether the peptide itself, contamination, inaccurate dosing, or poor handling was responsible, which is why quality-controlled sourcing matters